Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/103419
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Souffle/Spastizin Controls Secretory Vesicle Maturation during Zebrafish Oogenesis

AutorKanagaraj, Palsamy; Gautier-Stein, Amandine; Riedel, Dietmar; Schomburg, Christoph; Cerdà, Joan CSIC ORCID ; Vollack, Nadine; Dosch, Roland
Fecha de publicación26-jun-2014
EditorPublic Library of Science
CitaciónPLoS Genetics 10(6): e1004449 (2014)
ResumenDuring oogenesis, the egg prepares for fertilization and early embryogenesis. As a consequence, vesicle transport is very active during vitellogenesis, and oocytes are an outstanding system to study regulators of membrane trafficking. Here, we combine zebrafish genetics and the oocyte model to identify the molecular lesion underlying the zebrafish souffle (suf) mutation. We demonstrate that suf encodes the homolog of the Hereditary Spastic Paraplegia (HSP) gene SPASTIZIN (SPG15). We show that in zebrafish oocytes suf mutants accumulate Rab11b-positive vesicles, but trafficking of recycling endosomes is not affected. Instead, we detect Suf/Spastizin on cortical granules, which undergo regulated secretion. We demonstrate genetically that Suf is essential for granule maturation into secretion competent dense-core vesicles describing a novel role for Suf in vesicle maturation. Interestingly, in suf mutants immature, secretory precursors accumulate, because they fail to pinch-off Clathrin-coated buds. Moreover, pharmacological inhibition of the abscission regulator Dynamin leads to an accumulation of immature secretory granules and mimics the suf phenotype. Our results identify a novel regulator of secretory vesicle formation in the zebrafish oocyte. In addition, we describe an uncharacterized cellular mechanism for Suf/Spastizin activity during secretion, which raises the possibility of novel therapeutic avenues for HSP research. © 2014 Kanagaraj et al.
Descripción17 pages, 7 figures, supporting information https://doi.org/10.1371/journal.pgen.1004449
Versión del editorhttps://doi.org/10.1371/journal.pgen.1004449
URIhttp://hdl.handle.net/10261/103419
DOI10.1371/journal.pgen.1004449
Identificadoresdoi: 10.1371/journal.pgen.1004449
issn: 1553-7390
e-issn: 1553-7404
Aparece en las colecciones: (ICM) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
Kanagaraj_et_al_2014.pdf12,89 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

PubMed Central
Citations

13
checked on 11-abr-2024

SCOPUSTM   
Citations

16
checked on 11-abr-2024

WEB OF SCIENCETM
Citations

16
checked on 28-feb-2024

Page view(s)

274
checked on 19-abr-2024

Download(s)

216
checked on 19-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.